• 12210 Citations
  • 54 h-Index
19962021
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Primo N Lara is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 36 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2002 2021

CANCER CENTER SUPPORT GRANT-P30

DeGregorio, M., Matthews, D., Felton, J. S., deVere White, R. W., Radke, K., Lloyd, K. K., Gandara, D. R., Beckett, L. A., Gregg, J., Luciw, P. A., Kung, H., Gumerlock, P. H., Mack, P., Evans, C. P., Lara, P. N., Lam, K., Chen, X., Kelly, K., Cherry, S. R., Shacklett, B., Lloyd, K. C. K. & Chen, M.

National Institutes of Health

7/1/026/30/21

Project: Research project

Neoplasms
Organized Financing
Research
Research Personnel
Clinical Trials
Clinical Trials
Organizations
Neoplasms
Therapeutics
Contracts
Medical Oncology
Neoplasms
Research
Curriculum
Research Personnel
Bone Remodeling
Prostatic Neoplasms
Biomarkers
Bone and Bones
docetaxel
Clinical Trials
Neoplasms
Health Services Research
Communication
Research Personnel

Research Output 1996 2019

1 Citation (Scopus)

An open-label phase IB study to evaluate GSK3052230 in combination with paclitaxel and carboplatin, or docetaxel, in FGFR1-amplified non-small cell lung cancer

Morgensztern, D., Karaseva, N., Felip, E., Delgado, I., Burdaeva, O., Dómine, M., Lara, P. N., Paik, P. K., Lassen, U., Orlov, S., Trigo, J., Shomova, M., Baker-Neblett, K., Vasquez, J., Wang, X., Yan, L., Mitrica, I., DeYoung, M. P. & Garrido, P., Oct 1 2019, In : Lung Cancer. 136, p. 74-79 6 p.

Research output: Contribution to journalArticle

docetaxel
Carboplatin
Paclitaxel
Non-Small Cell Lung Carcinoma
Maximum Tolerated Dose

A Population-Based Study of Incidence and Survival of 1588 Thymic Malignancies: Results From the California Cancer Registry

Benjamin, D. J., Klapheke, A., Lara, P. N., Cress, R. D. & Riess, J., Jan 1 2019, (Accepted/In press) In : Clinical lung cancer.

Research output: Contribution to journalArticle

Registries
Cohort Studies
Survival
Incidence
Confidence Intervals

Considerations for the Next Clinical Trial Evaluating the Role of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma

Kim, H. L., Mayerson, E., Lara, P. N., Messing, E., Tangen, C., Shuch, B. M. & Vaishampayan, U., Jan 1 2019, In : European Urology Focus.

Research output: Contribution to journalComment/debate

Nephrectomy
Renal Cell Carcinoma
Clinical Trials
Immunotherapy
Therapeutics
4 Citations (Scopus)

Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate Cancer

Chen, W. S., Aggarwal, R., Zhang, L., Zhao, S. G., Thomas, G. V., Beer, T. M., Quigley, D. A., Foye, A., Playdle, D., Huang, J., Lloyd, P., Lu, E., Sun, D., Guan, X., Rettig, M., Gleave, M., Evans, C. P., Youngren, J., True, L., Lara, P. N. & 8 others, Kothari, V., Xia, Z., Chi, K. N., Reiter, R. E., Maher, C. A., Feng, F. Y., Small, E. J. & Alumkal, J. J., Jan 1 2019, In : European Urology.

Research output: Contribution to journalArticle

Castration
Prostatic Neoplasms
Catenins
Survival Analysis
Survival

Immunohistochemical expression of renin is a prognostic factor for recurrence in nonmetastatic renal cell carcinoma

de Almeida e Paula, F., Bezerra, S. M., da Cunha, I. W., Munhoz, G. C., Abreu, D., Lara, P. N., da Costa, W. H. & Zéqui, S. D. C., Jan 1 2019, (Accepted/In press) In : Urologic Oncology: Seminars and Original Investigations.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Renin
Recurrence
Disease-Free Survival
Survival Rate